Invention Grant
- Patent Title: TMEM219 antibodies and therapeutic uses thereof
-
Application No.: US18772062Application Date: 2024-07-12
-
Publication No.: US12221485B2Publication Date: 2025-02-11
- Inventor: Paolo Fiorina , Giovanni Amabile , Francesca D'Addio
- Applicant: ENTHERA S.R.L.
- Applicant Address: IT Milan
- Assignee: ENTHERA S.R.L.
- Current Assignee: ENTHERA S.R.L.
- Current Assignee Address: IT Milan
- Agency: Fenwick & West LLP
- Priority: EP19209521 20191115,EP20167459 20200401
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P3/10 ; C12N15/63
Abstract:
The present invention relates to antibodies or antigen binding fragments thereof that bind specifically to the IGFBP3 receptor, namely TMEM219, to methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.
Public/Granted literature
- US20240368290A1 TMEM219 ANTIBODIES AND THERAPEUTIC USES THEREOF Public/Granted day:2024-11-07
Information query
